CTOs on the Move

Synexis

www.synexis.com

 
Synexis is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

PerioSciences

PerioSciences antioxidant infused oral gel, toothpaste, and mouth rinse help keep your teeth and gums healthy. Check out our entire line here!

Grembowiec and Associates Inc

Grembowiec and Associates Inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ControlRad Systems

ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals.

Interstate Blood Bank Inc

Interstate Blood Bank Inc is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accredo Health Group

Headquartered in Memphis, Tennessee, Accredo Health Group, Inc., provides specialty pharmacy and related services for patients with certain complex and chronic conditions through our unique Therapeutic Resource Centers. Accredo is a wholly owned subsidiary of Express Scripts. Accredo’s Therapeutic Resource Centers are segmented by therapy and provide targeted therapy management programs for the following therapeutic areas: Rheumatoid arthritis Multiple sclerosis Oncology Hepatitis C Immune disorders Pulmonary arterial hypertension Hemophilia Other specialty therapies with dedicated care teams (RSV, growth deficiencies, etc.) Our services cover the range of needs posed by specialty pharmacy care. Our pharmacists and other healthcare professionals talk frequently with patients over the phone, helping them follow their treatment and educating them about their condition. And our reimbursement specialists provide b enefits research services, with an explanation to the patient or patient’s caregiver of any financial responsibility he/she may have plus prior authorization determination.